- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
12 Keratoconus Trials near New York, NY
Power is an online platform that helps thousands of Keratoconus patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerCorneal Collagen Crosslinking for Keratoconus
Trial Details
Key Eligibility Criteria
170 Participants Needed
Corneal Collagen Crosslinking for Keratoconus
Trial Details
Key Eligibility Criteria
160 Participants Needed
Corneal Collagen Crosslinking for Keratoconus
Trial Details
Key Eligibility Criteria
170 Participants Needed
Corneal Cross-Linking for Keratoconus
Trial Details
Key Eligibility Criteria
150 Participants Needed
Corneal Tissue Inlay for Keratoconus
Trial Details
Key Eligibility Criteria
20 Participants Needed
Wavefront Guided Scleral Lenses for Keratoconus and Astigmatism
Trial Details
Key Eligibility Criteria
100 Participants Needed
Corneal Collagen Crosslinking for Keratoconus
Trial Details
Key Eligibility Criteria
160 Participants Needed
Corneal Collagen Crosslinking for Keratoconus
Trial Details
Key Eligibility Criteria
160 Participants Needed
Corneal Collagen Crosslinking + Intacs for Keratoconus
Trial Details
Key Eligibility Criteria
160 Participants Needed
Ocular Lubricant for Dry Eye Syndrome
Trial Details
Key Eligibility Criteria
185 Participants Needed
TTAX03 for Dry Eye Syndrome
Trial Details
Key Eligibility Criteria
72 Participants Needed
Dupilumab for Conjunctivitis
Trial Details
Key Eligibility Criteria
42 Participants Needed
Why Other Patients Applied
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I changed my diet in 2020 and I’ve lost 95 pounds from my highest weight (283). I am 5’3”, female, and now 188. I still have a 33 BMI. I've been doing research on alternative approaches to continue my progress, which brought me here to consider clinical trials."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Keratoconus clinical trials in New York, NY pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Keratoconus clinical trials in New York, NY work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Keratoconus trials in New York, NY 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in New York, NY for Keratoconus is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in New York, NY several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Keratoconus medical study in New York, NY?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Keratoconus clinical trials in New York, NY?
Most recently, we added TTAX03 for Dry Eye Syndrome, Ocular Lubricant for Dry Eye Syndrome and Corneal Cross-Linking for Keratoconus to the Power online platform.